Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis.
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis. N Engl J Med. 2018 10 04; 379(14):1313-1321.
View in:
PubMed
subject areas
Administration, Oral
Adult
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Heterocyclic Compounds
Humans
Janus Kinase Inhibitors
Male
Middle Aged
Psoriasis
Severity of Illness Index
TYK2 Kinase
authors with profiles
Kenneth Gordon